Technical Analysis for PAA - PharmAust Limited  

Grade Last Price % Change Price Change
D 0.250 -13.79% -0.040
PAA closed down 13.79 percent on Wednesday, April 24, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Gilligan's Island Buy Setup Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Boomer Sell Setup Bearish Swing Setup -13.79%
Volume Surge Other -13.79%
Narrow Range Bar Range Contraction -13.79%
Inside Day Range Contraction -13.79%

   Recent Intraday Alerts

Alert Time
1.5x Volume Pace 1 day ago
Down 10% 1 day ago
Gapped Down (Full) 1 day ago
Down 2 ATRs 1 day ago
Down 1 ATR 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PharmAust Limited   Description

Pharmaust Limited is a drug discovery and development company. The principal activities of the Company are to develop its own drug discovery intellectual property, namely approximately three platforms for the treatment of different types of cancers in humans and animals, as well as providing specialized medicinal and synthetic chemistry services on a contract basis to clients. The Company's segments are Corporate and Pharmaceutical. The Pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Corporate segment covers all the corporate overhead expenses. Its subsidiaries include Pitney Pharmaceuticals Pty Ltd, which is engaged in business of developing therapeutic cancer products, and Epichem Pty Ltd, which offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for over-the-counter and generic drugs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Health Pharmaceutical Cancer Drugs Pharmaceuticals Intellectual Property Cancers Pharmacy Health Sciences Pharmaceutical Industry Pharmaceuticals Policy Animals Drug Discovery Medication Pharmaceutical Industry In China Science And Technology In The People's Republic Of China Humans Pharmaceutical Sciences Generic Drug Medicinal Chemistry Pharmaceutical Industries

Is PAA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.535
52 Week Low 0.065
Average Volume 1,693,026
200-Day Moving Average 0.149
50-Day Moving Average 0.311
20-Day Moving Average 0.339
10-Day Moving Average 0.309
Average True Range 0.027
RSI (14) 33.77
ADX 37.01
+DI 19.720
-DI 34.840
Chandelier Exit (Long, 3 ATRs) 0.354
Chandelier Exit (Short, 3 ATRs) 0.316
Upper Bollinger Bands 0.423
Lower Bollinger Band 0.256
Percent B (%b) -0.04
BandWidth 49.042
MACD Line -0.012
MACD Signal Line 0.002
MACD Histogram -0.0137
Fundamentals Value
Market Cap 79.06 Million
Num Shares 316 Million
EPS -0.01
Price-to-Earnings (P/E) Ratio -35.71
Price-to-Sales 11.12
Price-to-Book 4.45
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.288
Resistance 3 (R3) 0.287 0.273 0.281
Resistance 2 (R2) 0.273 0.264 0.274 0.279
Resistance 1 (R1) 0.262 0.258 0.268 0.263 0.277
Pivot Point 0.248 0.248 0.251 0.249 0.248
Support 1 (S1) 0.237 0.239 0.243 0.238 0.223
Support 2 (S2) 0.223 0.233 0.224 0.221
Support 3 (S3) 0.212 0.223 0.219
Support 4 (S4) 0.213